{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:06Z","timestamp":1761058686619},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,4,29]],"date-time":"2007-04-29T00:00:00Z","timestamp":1177804800000},"content-version":"vor","delay-in-days":3739,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,2]]},"abstract":"<jats:p>Quantitative determinations of the inflammatory mediators in nasal secretions were performed and correlated with the objective nasal symptoms within 1 h after nasal allergen challenge (NAC). Twenty\u2010six patients with seasonal allergic rhinitis were enrolled outside the pollen season. All measurements were performed before (as a baseline control) and at 1, 5, 10, 30, and 60 min after NAC. This study aimed to clarify the pathogenic mechanism of the early\u2010phase reaction (EPR) by monitoring the evolution of early\u2010phase mediators in nasal secretions and the presence of nasal symptoms during this period. The results showed that, after NAC, the maximal mediator concentration was already reached after 1 min for histamine (124 ng\/g), 5 min for tryptase (56 \u03bcU\/g), and 5\u201010 min for leukotriene C<jats:sub>4<\/jats:sub> (40 ng\/g). Itching and sneezing started as early as 20\u201030 s, and they were predominant symptoms within 5 min. Rhinorrhea and nasal obstruction started a few minutes after NAC and lasted until more than 1 h after NAC. There was no significant correlation between any single mediator and nasal symptoms during the sampling period. In conclusion, this study demonstrated that during the EPR the presence of nasal symptoms involves a complex mechanism, reflecting the interaction between the mediators released by inflammatory cells, and the receptors on different target organs. When evaluating symptoms during the EPR, one must consider not only the severity of these symptoms but also the time period within which these symptoms occur. For the symptoms of nasal obstruction and rhinorrhea, the early\u2010phase reaction often lasted more than 1 h.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb00970.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:23:50Z","timestamp":1179102230000},"page":"162-167","source":"Crossref","is-referenced-by-count":35,"title":["An approach to the understanding of the nasal early\u2010phase reaction induced by nasal allergen challenge"],"prefix":"10.1111","volume":"52","author":[{"given":"D.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Smitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Waterschoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,29]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"203","volume-title":"Rhinitis and asthma","author":"Dahl R.","year":"1990"},{"key":"e_1_2_1_3_2","first-page":"597","article-title":"Mediator release after nasal airway challenge with allergen","volume":"128","author":"Naclerio RM","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507113130201"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1991.tb04225.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1993.tb00688.x"},{"key":"e_1_2_1_7_2","first-page":"189","volume-title":"Allergic and vasomotor rhinitis: pathophysiological aspects","author":"Bisgaard H","year":"1987"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198406213102502"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236855"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456329102800311"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02484433"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1981.tb01597.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(92)90460-J"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1987.tb02052.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016489409126103"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1993.tb00691.x"},{"key":"e_1_2_1_17_2","first-page":"248","article-title":"Pathophysiology of allergic rhinitis","volume":"4","author":"Mygind N.","year":"1994","journal-title":"Eur Respir Rev"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1995.tb00063.x"},{"key":"e_1_2_1_19_2","first-page":"25","article-title":"The activity of recent anti\u2010allergic drugs in the treatment of seasonal allergic rhinitis","volume":"50","author":"Wang D","year":"1996","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-198906000-00006"},{"key":"e_1_2_1_21_2","first-page":"98","article-title":"Relevance of histamine and tryptase concentrations in nasal secretions after nasal challenges with phosphate buffered saline and allergen","volume":"5","author":"Wang D","year":"1994","journal-title":"Med Inflamm"},{"key":"e_1_2_1_22_2","first-page":"463","article-title":"Leukotriene inhibitors and antagonists in asthma","volume":"75","author":"Spector SL","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.3.791"},{"key":"e_1_2_1_24_2","first-page":"652","volume-title":"Asthma and rhinitis","author":"Baraniuk J","year":"1995"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb00970.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb00970.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:38:22Z","timestamp":1698385102000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb00970.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb00970.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb00970.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}